Somatosensory function in patients with secondary adrenal insufficiency treated with two different doses of hydrocortisone-Results from a randomized controlled trial.
Low cortisol levels are associated with several functional pain syndromes. In patients with secondary adrenal insufficiency (SAI), the lack in endogenous cortisol production is substituted by the administration of oral hydrocortisone (HC). Our previous study showed that a lower dose of HC led to an...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5501533?pdf=render |
id |
doaj-ea2e0ae6c7b44081a07b07b4c0ad96f1 |
---|---|
record_format |
Article |
spelling |
doaj-ea2e0ae6c7b44081a07b07b4c0ad96f12020-11-25T02:47:45ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01127e018032610.1371/journal.pone.0180326Somatosensory function in patients with secondary adrenal insufficiency treated with two different doses of hydrocortisone-Results from a randomized controlled trial.Jorien Werumeus BuningKarl-Heinz KonopkaPauline BrummelmanJanneke KoertsRobin P F DullaartGerrit van den BergMelanie M van der KlauwOliver TuchaBruce H R WolffenbuttelAndré P van BeekLow cortisol levels are associated with several functional pain syndromes. In patients with secondary adrenal insufficiency (SAI), the lack in endogenous cortisol production is substituted by the administration of oral hydrocortisone (HC). Our previous study showed that a lower dose of HC led to an increase in reported subjective pain symptoms. Whether different doses of HC substitution alter somatosensory functioning in SAI patients has not been established yet.In this randomized double blind cross-over trial, forty-six patients with SAI participated. Patients randomly received either first a lower dose (0.2-0.3 mg HC/kg body weight/day) for 10 weeks followed by a higher dose (0.4-0.6 mg HC/kg body weight/day) for another 10 weeks, or vice versa. After each treatment period, blood samples were drawn and somatosensory functioning was assessed by determining the mechanical detection threshold (MDT), mechanical pain threshold (MPT), mechanical pain sensitivity (MPS) and the pain pressure threshold (PPT), according to the Quantitative Sensory Testing (QST) battery by the German Network on Neuropathic Pain.The administration of the higher dose of HC resulted in significantly higher levels of cortisol (mean [SD] 748 [245] nmol/L) than the lower dose (537 [250] nmol/L, P<0.001). No differences were found in MDT, MPT, MPS and PPT z-scores between the two doses of HC. Furthermore, the number of patients showing sensory abnormalities did not differ between the two different doses.The results suggest that the dose of HC has no impact on somatosensory functioning in response to mechanical stimuli in patients with SAI, despite previously found altered subjective pain reports.http://europepmc.org/articles/PMC5501533?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jorien Werumeus Buning Karl-Heinz Konopka Pauline Brummelman Janneke Koerts Robin P F Dullaart Gerrit van den Berg Melanie M van der Klauw Oliver Tucha Bruce H R Wolffenbuttel André P van Beek |
spellingShingle |
Jorien Werumeus Buning Karl-Heinz Konopka Pauline Brummelman Janneke Koerts Robin P F Dullaart Gerrit van den Berg Melanie M van der Klauw Oliver Tucha Bruce H R Wolffenbuttel André P van Beek Somatosensory function in patients with secondary adrenal insufficiency treated with two different doses of hydrocortisone-Results from a randomized controlled trial. PLoS ONE |
author_facet |
Jorien Werumeus Buning Karl-Heinz Konopka Pauline Brummelman Janneke Koerts Robin P F Dullaart Gerrit van den Berg Melanie M van der Klauw Oliver Tucha Bruce H R Wolffenbuttel André P van Beek |
author_sort |
Jorien Werumeus Buning |
title |
Somatosensory function in patients with secondary adrenal insufficiency treated with two different doses of hydrocortisone-Results from a randomized controlled trial. |
title_short |
Somatosensory function in patients with secondary adrenal insufficiency treated with two different doses of hydrocortisone-Results from a randomized controlled trial. |
title_full |
Somatosensory function in patients with secondary adrenal insufficiency treated with two different doses of hydrocortisone-Results from a randomized controlled trial. |
title_fullStr |
Somatosensory function in patients with secondary adrenal insufficiency treated with two different doses of hydrocortisone-Results from a randomized controlled trial. |
title_full_unstemmed |
Somatosensory function in patients with secondary adrenal insufficiency treated with two different doses of hydrocortisone-Results from a randomized controlled trial. |
title_sort |
somatosensory function in patients with secondary adrenal insufficiency treated with two different doses of hydrocortisone-results from a randomized controlled trial. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2017-01-01 |
description |
Low cortisol levels are associated with several functional pain syndromes. In patients with secondary adrenal insufficiency (SAI), the lack in endogenous cortisol production is substituted by the administration of oral hydrocortisone (HC). Our previous study showed that a lower dose of HC led to an increase in reported subjective pain symptoms. Whether different doses of HC substitution alter somatosensory functioning in SAI patients has not been established yet.In this randomized double blind cross-over trial, forty-six patients with SAI participated. Patients randomly received either first a lower dose (0.2-0.3 mg HC/kg body weight/day) for 10 weeks followed by a higher dose (0.4-0.6 mg HC/kg body weight/day) for another 10 weeks, or vice versa. After each treatment period, blood samples were drawn and somatosensory functioning was assessed by determining the mechanical detection threshold (MDT), mechanical pain threshold (MPT), mechanical pain sensitivity (MPS) and the pain pressure threshold (PPT), according to the Quantitative Sensory Testing (QST) battery by the German Network on Neuropathic Pain.The administration of the higher dose of HC resulted in significantly higher levels of cortisol (mean [SD] 748 [245] nmol/L) than the lower dose (537 [250] nmol/L, P<0.001). No differences were found in MDT, MPT, MPS and PPT z-scores between the two doses of HC. Furthermore, the number of patients showing sensory abnormalities did not differ between the two different doses.The results suggest that the dose of HC has no impact on somatosensory functioning in response to mechanical stimuli in patients with SAI, despite previously found altered subjective pain reports. |
url |
http://europepmc.org/articles/PMC5501533?pdf=render |
work_keys_str_mv |
AT jorienwerumeusbuning somatosensoryfunctioninpatientswithsecondaryadrenalinsufficiencytreatedwithtwodifferentdosesofhydrocortisoneresultsfromarandomizedcontrolledtrial AT karlheinzkonopka somatosensoryfunctioninpatientswithsecondaryadrenalinsufficiencytreatedwithtwodifferentdosesofhydrocortisoneresultsfromarandomizedcontrolledtrial AT paulinebrummelman somatosensoryfunctioninpatientswithsecondaryadrenalinsufficiencytreatedwithtwodifferentdosesofhydrocortisoneresultsfromarandomizedcontrolledtrial AT jannekekoerts somatosensoryfunctioninpatientswithsecondaryadrenalinsufficiencytreatedwithtwodifferentdosesofhydrocortisoneresultsfromarandomizedcontrolledtrial AT robinpfdullaart somatosensoryfunctioninpatientswithsecondaryadrenalinsufficiencytreatedwithtwodifferentdosesofhydrocortisoneresultsfromarandomizedcontrolledtrial AT gerritvandenberg somatosensoryfunctioninpatientswithsecondaryadrenalinsufficiencytreatedwithtwodifferentdosesofhydrocortisoneresultsfromarandomizedcontrolledtrial AT melaniemvanderklauw somatosensoryfunctioninpatientswithsecondaryadrenalinsufficiencytreatedwithtwodifferentdosesofhydrocortisoneresultsfromarandomizedcontrolledtrial AT olivertucha somatosensoryfunctioninpatientswithsecondaryadrenalinsufficiencytreatedwithtwodifferentdosesofhydrocortisoneresultsfromarandomizedcontrolledtrial AT brucehrwolffenbuttel somatosensoryfunctioninpatientswithsecondaryadrenalinsufficiencytreatedwithtwodifferentdosesofhydrocortisoneresultsfromarandomizedcontrolledtrial AT andrepvanbeek somatosensoryfunctioninpatientswithsecondaryadrenalinsufficiencytreatedwithtwodifferentdosesofhydrocortisoneresultsfromarandomizedcontrolledtrial |
_version_ |
1724751657883926528 |